Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2066266

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2066266

Probiotic Supplements Market by Product Form (Tablets, Capsules, Powder, Gummies & Chewable, Liquid, and Other Product Forms), Health Application, End User, Distribution Channel, Ingredient (Bacteria & Yeast), and Region - Global Forecast to 2031

PUBLISHED:
PAGES: 359 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

The probiotic supplements market is projected to expand from USD 10.60 billion in 2026 to USD 16.69 billion by 2031, at a high CAGR of 9.5%.

Scope of the Report
Years Considered for the Study2022-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD Million/Billion) and Volume (KT)
SegmentsProduct Form, Health Application, End User, Distribution Channel, Ingredient, and Region
Regions coveredNorth America, Europe, Asia Pacific, South America, RoW

Consumer awareness of digestive health, microbiome balance, immune support, and preventive healthcare consumption is driving market growth. Increasing demand for functional nutrition products and a strong shift towards science-based dietary supplements are contributing to this growth.

Probiotic Supplements Market - IMG1

There is an increased emphasis on developing novel probiotic formulas across all format types, including capsules, gummies & chewable, powders, tablets, and liquids to optimize convenience, stability and targeted health claims. Likewise, a boost to microbiome investment, strain-specific formulations, and clinically validated probiotic ingredients is further driving product innovation in this space. Companies are also broadening their product ranges to support multiple applications such as gastrointestinal health, immune health, women's health, oral health, metabolic health and pediatric health.

Challenges in this market include regulatory nuances, such as stipulations on health claims, concerns about the stability of live organisms, and the high costs related to clinical trials and strain development. However, the increasing trend towards customized nutrition, the growing use of electronic channels, and the demand for functionally driven wellness products present significant growth opportunities for probiotic supplement manufacturers worldwide.

"By product form, gummies & chewables are expected to be the fastest-growing segment during the forecast period."

Gummies and chewables are expected to be the fastest-growing product form segment in the probiotic supplements market during the forecast period. The market for probiotic gummies and chewables has been experiencing significant growth due to rising consumer demand for easy-to-eat, flavored supplement forms. This category is especially favored by children and younger populations.

Recently, many companies have been developing probiotic gummy formulas with or without added vitamins and mineral premixes and prebiotics to support structure/function health claims such as digestive and immune system support. These formulas offer benefits such as improved mouthfeel, portability, and better compliance compared with traditional supplement forms.

Capsules currently have the largest market share among all functional food/capsule products in the probiotic supplements market. This is because capsules are highly stable, provide accurate dosing, have a longer shelf life, and are easy for most adult consumers to take. Successfully delivering multiple probiotic strains in a single dosage form is also an additional benefit of capsules, and hence their applicability across all channels of distribution, such as pharmacies, drugstores, and healthcare channels, among others.

"By health application, immunity support is expected to be the fastest-growing segment during the forecast period."

Immunity support is expected to be the fastest-growing health application segment in the probiotic supplements market during the forecast period. Rising consumer awareness of immune health, preventive healthcare, and wellness is a major factor fueling the acceptance of probiotic supplements designed to support immune health.

More manufacturers are now creating specialized probiotic formulations with clinically validated strains of bacteria and yeast to help restore the balance of the gut microbiome and achieve a stronger immune response. Growing consumer knowledge of the impact of gut health on the immune system is also driving an increased demand for probiotic supplements targeted at immunity.

Digestive health currently accounts for the largest share of the probiotic supplement market, driven by ever-increasing consumer awareness of digestive health, gut flora balance, and digestive support. Probiotic supplements are most commonly used to enhance digestion, intestinal health, and healthy gut flora across consumers of all age groups.

"By end user, the children segment is expected to witness the fastest growth during the forecast period."

Children are anticipated to be the fastest-growing end-user segment in the probiotic supplements market during the forecast period. Rising parental awareness about children's gut health, immunity building, and digestive health is boosting the consumption of probiotic supplements among children.

Manufacturers are now leveraging more pleasant taste profiles and more convenient administration forms (such as gummies, powders, chewables, and liquid drops) of child-friendly probiotics in the form of probiotic products. Rising awareness of preventive pediatrics, as well as other microbiome-centric nutrition solutions, has accelerated segment growth.

The application 'adults' now captures the largest market share in the probiotic supplements market on account of high consumption of dietary supplements targeted at digestive health, immune system boosting, metabolic health and general preventive healthcare. Increasing health consciousness and growing use of daily wellness supplements by working population segments are driving the segment growth.

"Asia Pacific is projected to be the fastest-growing regional market for probiotic supplements during the forecast period."

Asia Pacific is projected to be the fastest-growing regional market for probiotic supplements during the forecast period, owing to increasing consumer awareness regarding digestive wellness, immunity support, and preventive healthcare across the region. Rising disposable incomes, expanding middle-class population, rapid urbanization, and changing dietary habits are significantly contributing to the growing adoption of probiotic supplements in countries such as China, India, Japan, South Korea, and Australia.

Growing consumer inclination toward healthy lifestyles, leading to enhanced adoption of probiotic capsules, gummies, powders, chewable, and liquid formulae, is significantly contributing to the expansion of the Asia Pacific market. Increasing adoption of functional foods and dietary supplements, wider retail availability, and growing penetration of e-commerce sites are other factors adding to the overall industry growth.

In addition, companies are investing heavily in new product development, local formulations and broadening of distribution channels to increase their regional penetration. Additionally, rising emphasis on preventive care, pediatrics, women 's health and customized health solutions is anticipated to support healthy growth in the market over the forecast period.

"By distribution channel, the E-commerce segment is expected to witness the fastest growth during the forecast period."

E-commerce is expected to be the fastest-growing distribution channel segment of the probiotic supplements market during the forecast period. The rise in product digitization, the surge in online purchasing of health products, and consumers' inclination toward ease of shopping are supporting the rapid growth of online sales of probiotic supplements.

Consumers have more choices of products, subscription purchase options, product comparisons, customer reviews, and even 24/7 access to the most premium and limited-edition probiotic products through online platforms. Producers are increasingly using direct-to-consumer approaches and digital marketing campaigns to boost their success in online sales.

Pharmacies and drugstores have the largest market share in the probiotic supplements market due to high consumer trust, product recommendations, and the wide availability of probiotics positioned for clinical use. Customers continue to report buying health-related probiotics at the pharmacy, and this behavior is supported by the credibility and reliability of these retailers.

"By ingredient, the Saccharomyces boulardii segment is expected to witness the fastest growth during the forecast period."

Saccharomyces boulardii is expected to be the fastest-growing ingredient segment during the forecast period across the probiotic supplements market. Because there is more scientific research supporting the efficacy of Saccharomyces boulardii in managing digestive and gastrointestinal health and antibiotic-associated digestive disorders, the demand for Saccharomyces boulardii-based probiotic supplements is on the increase.

As a result of its stability, survivability and compatibility with a wide variety of supplement formats, Saccharomyces boulardii is being integrated into targeted digestive health and immunity support products by an increasing number of manufacturers. Segments are further expanding as consumers demand higher levels of accuracy and strength associated with specific probiotic strains that offer proven benefits according to clinical studies.

Lactobacilli represent the dominant segment of the probiotic supplements market currently. This is due to their presence in the largest number of applications, including digestive health, immune health, women 's health and general wellness. Moreover, strains of lactobacilli are the most utilized in probiotic supplement formulations because of the widespread clinical support, high awareness, and applications in capsule, powder, gummy and liquid formats.

In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the Probiotic supplements market.

  • By Company Type: Tier 1 - 30%, Tier 2 - 25%, and Tier 3 - 45%
  • By Designation: CXOs - 25%, Managers - 35%, Others - 40%
  • By Region: North America - 20%, Europe - 30%, Asia Pacific - 35%, South America - 10%, and Rest of the World -5%

Prominent companies in the market include Nestle S.A. (Switzerland), Yakult Honsha Co., Ltd. (Japan), Symrise AG (Germany), Kerry Group plc (Ireland), Herbalife Ltd. (UK), Morinaga Milk Industry Co., Ltd. (Japan), Amway Corporation (UK), Jarrow Formulas, Inc., Biogaia (Sweden), and others.

Research Coverage

This research report categorizes the probiotic supplements market by Product Form (Tablets, Capsules, Powder, Gummies & Chewable, Liquid, and Other Product Forms), Health Application (Digestive Health, Immunity Support, Women's Health, Metabolic Health, Gut Health, Oral Health, and Other Health Applications), End User (Infant, Children, Adults, and Geriatric Population), Distribution Channel (Hypermarkets/Supermarkets, Pharmacies/Drugstores, Specialty Stores, E-commerce, and Other Distribution Channel), Ingredient (Bacteria (Lactobacilli, Bifidobacterium, Bacillus, Streptococcus Thermophilus) and Yeast (Saccharomyces Boulardii, Other Yeasts)), and Region (North America, Europe, Asia Pacific, South America, and Rest of the World).

The report's scope encompasses detailed information on the major factors, including drivers, restraints, challenges, and opportunities, which influence the growth of the Probiotic supplements industry. A thorough analysis of the key industry players has been carried out to provide insights into their business, services, key strategies, contracts, partnerships, agreements, service launches, mergers & acquisitions, and recent developments associated with the Probiotic supplements market. This report provides a competitive analysis of emerging startups in the Probiotic supplements market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscape, among others.

Reasons to Buy This Report

The report provides market leaders/new entrants with information on the closest approximations of revenue numbers for the overall Probiotic supplements and its subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

  • Analysis of key drivers (Increasing consumer awareness regarding digestive health and immunity support for Probiotic supplements), restraints (Stability and shelf-life challenges associated with probiotic strains), opportunities (Expansion of personalized nutrition and targeted probiotic formulations), and challenges (Managing formulation complexity across multiple probiotic strains), influencing the growth of the probiotic supplements market
  • Product Development/Innovation: Detailed insights into research & development activities and new product launches in the Probiotic supplements market
  • Market Development: Comprehensive information about the lucrative market analysis of probiotic supplements across varied regions
  • Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the Probiotic supplements market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as Nestle S.A. (Switzerland), Yakult Honsha Co., Ltd. (Japan), Symrise AG (Germany), Kerry Group plc (Ireland), Herbalife Ltd. (UK), Morinaga Milk Industry Co., Ltd. (Japan), Amway Corporation (UK), Jarrow Formulas, Inc. (UK), BioGaia (Sweden), Metagenics, Inc. (UK), OptiBiotix Health Plc (UK), Nature's Way Products, LLC (UK), Optibac Probiotics Ltd. (UK), AB-BIOTICS S.A. (Spain), Lifeway Foods, Inc. (UK), and other players in the probiotic supplements market.
Product Code: FB 10527

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE AND SEGMENTATION
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.4 YEARS CONSIDERED
  • 1.5 CURRENCY CONSIDERED
  • 1.6 STAKEHOLDERS

2 EXECUTIVE SUMMARY

  • 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS IN PROBIOTIC SUPPLEMENTS MARKET
  • 2.4 HIGH-GROWTH SEGMENTS
  • 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PROBIOTIC SUPPLEMENTS MARKET
  • 3.2 PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM AND REGION
  • 3.3 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT
  • 3.4 PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL
  • 3.5 PROBIOTIC SUPPLEMENTS MARKET, BY END USER
  • 3.6 PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION
  • 3.7 PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Rising prevalence of digestive health disorders and gastrointestinal diseases
      • 4.2.1.2 Growing consumer focus on preventive healthcare and wellness
      • 4.2.1.3 Increasing scientific evidence supporting microbiome health benefits
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 Regulatory complexities and health claim restrictions
      • 4.2.2.2 Stability and shelf-life challenges of live probiotic organisms
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Expansion of personalized nutrition and microbiome-based supplementation
      • 4.2.3.2 Innovation in delivery formats like gummies, chewables, and stick packs
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Scientific debate and inconsistent clinical outcomes across strains
      • 4.2.4.2 Regulatory restrictions on health claims and marketing communications
  • 4.3 UNMET NEEDS AND WHITE SPACES
    • 4.3.1 UNMET NEEDS IN PROBIOTIC SUPPLEMENTS MARKET
      • 4.3.1.1 Improved probiotic survivability and delivery efficiency
      • 4.3.1.2 Cost-effective and scalable solutions for emerging markets
      • 4.3.1.3 Stronger clinical validation and healthcare adoption
    • 4.3.2 WHITE SPACE OPPORTUNITIES
      • 4.3.2.1 Women's microbiome and hormonal health solutions
      • 4.3.2.2 Postbiotic and next-generation microbiome products
      • 4.3.2.3 Probiotic supplements for mental wellness and the gut-brain axis
      • 4.3.2.4 Personalized digital microbiome ecosystems
  • 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
    • 4.4.1 INTERCONNECTED MARKETS
    • 4.4.2 CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
    • 4.5.1 KEY MOVES AND STRATEGIC FOCUS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.1.2 BARGAINING POWER OF SUPPLIERS
    • 5.1.3 BARGAINING POWER OF BUYERS
    • 5.1.4 THREAT OF SUBSTITUTES
    • 5.1.5 THREAT OF NEW ENTRANTS
  • 5.2 MACROECONOMICS OUTLOOK
    • 5.2.1 RISING GLOBAL POPULATION AND INCREASING DEMAND FOR PREVENTIVE HEALTHCARE
    • 5.2.2 EXPANSION OF E-COMMERCE AND DIGITAL HEALTH ECOSYSTEMS
  • 5.3 SUPPLY CHAIN ANALYSIS
    • 5.3.1 UPSTREAM (RAW MATERIALS & INGREDIENT SUPPLIERS)
    • 5.3.2 INGREDIENT PROCESSING & MANUFACTURING
    • 5.3.3 SUPPLEMENT MANUFACTURING & FORMULATION
    • 5.3.4 DISTRIBUTION & COMMERCIALIZATION
    • 5.3.5 END USERS
    • 5.3.6 SUPPORTING ECOSYSTEM
  • 5.4 ECOSYSTEM ANALYSIS
  • 5.5 PRICING ANALYSIS
    • 5.5.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT FORM
    • 5.5.2 AVERAGE SELLING PRICE, BY REGION
  • 5.6 TRADE ANALYSIS
    • 5.6.1 IMPORT SCENARIO (HS CODE 300490)
    • 5.6.2 EXPORT SCENARIO (HS CODE 300490)
  • 5.7 KEY CONFERENCES AND EVENTS, 2026-2027
  • 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.9 INVESTMENT AND FUNDING SCENARIO
  • 5.10 CASE STUDY ANALYSIS
    • 5.10.1 PENDULUM THERAPEUTICS INTRODUCED GLUCOSE CONTROL PROBIOTIC FOR METABOLIC HEALTH
    • 5.10.2 NESTLE HEALTH SCIENCE LAUNCHED PERSONALIZED NUTRITION PLATFORM TO SUPPORT GUT HEALTH
  • 5.11 IMPACT OF 2025 US TARIFF - PROBIOTIC SUPPLEMENTS MARKET
    • 5.11.1 INTRODUCTION
    • 5.11.2 KEY TARIFF RATES
    • 5.11.3 PRICE IMPACT ANALYSIS
    • 5.11.4 IMPACT ON COUNTRIES/REGIONS
      • 5.11.4.1 US
      • 5.11.4.2 Europe
      • 5.11.4.3 Asia Pacific
    • 5.11.5 IMPACT ON END-USE INDUSTRIES
    • 5.11.6 US TARIFF UPDATE (2026) AND LEGAL DEVELOPMENTS

6 TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

  • 6.1 KEY TECHNOLOGIES
    • 6.1.1 MICROENCAPSULATION
    • 6.1.2 GENOMIC & METAGENOMIC SEQUENCING
    • 6.1.3 LYOPHILIZATION (FREEZE-DRYING)
  • 6.2 COMPLEMENTARY TECHNOLOGIES
    • 6.2.1 AI-DRIVEN PERSONALIZATION & DIGITAL HEALTH INTEGRATION
    • 6.2.2 COLD-CHAIN INNOVATION & ADVANCED STABILITY LOGISTICS
  • 6.3 ADJACENT TECHNOLOGIES
    • 6.3.1 PRECISION FERMENTATION
    • 6.3.2 SYNTHETIC BIOLOGY & STRAIN ENGINEERING
  • 6.4 TECHNOLOGY ROADMAP
  • 6.5 PATENT ANALYSIS
    • 6.5.1 INTRODUCTION
    • 6.5.2 LIST OF MAJOR PATENTS, MARCH 2020-DECEMBER 2024
  • 6.6 FUTURE APPLICATIONS
    • 6.6.1 PERSONALIZED MICROBIOME-BASED NUTRITION
    • 6.6.2 MENTAL WELLNESS AND GUT-BRAIN HEALTH
    • 6.6.3 WOMEN'S HEALTH SOLUTIONS
    • 6.6.4 LIVE BIOTHERAPEUTIC PRODUCTS (LBPS)
    • 6.6.5 AI-ENABLED PERSONALIZED PROBIOTIC ECOSYSTEMS
  • 6.7 IMPACT OF AI/GEN AI ON PROBIOTIC SUPPLEMENTS INDUSTRY
    • 6.7.1 TOP USE CASES AND MARKET POTENTIALS
    • 6.7.2 BEST PRACTICES IN PROBIOTIC SUPPLEMENTS INDUSTRY
    • 6.7.3 CASE STUDIES RELATED TO AI IMPLEMENTATION IN PROBIOTIC SUPPLEMENTS MARKET
    • 6.7.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
    • 6.7.5 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN PROBIOTIC SUPPLEMENTS MARKET
  • 6.8 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
    • 6.8.1 DSM-FIRMENICH: AI4B.IO FOR BIOSCIENCE INNOVATION
    • 6.8.2 NESTLE HEALTH SCIENCE: PERSONALIZED NUTRITION PLATFORM
    • 6.8.3 VIOME: AI-POWERED MICROBIOME PERSONALIZATION

7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES

  • 7.1 REGIONAL REGULATIONS AND COMPLIANCE
    • 7.1.1 REGULATORY FRAMEWORK
      • 7.1.1.1 North America
        • 7.1.1.1.1 US
        • 7.1.1.1.2 Canada
        • 7.1.1.1.3 Mexico
      • 7.1.1.2 Europe
        • 7.1.1.2.1 Germany
        • 7.1.1.2.2 UK
        • 7.1.1.2.3 France
        • 7.1.1.2.4 Italy
        • 7.1.1.2.5 Spain
        • 7.1.1.2.6 Rest of Europe
      • 7.1.1.3 Asia Pacific
        • 7.1.1.3.1 China
        • 7.1.1.3.2 India
        • 7.1.1.3.3 Japan
        • 7.1.1.3.4 South Korea
        • 7.1.1.3.5 Australia & New Zealand
        • 7.1.1.3.6 Rest of Asia Pacific
      • 7.1.1.4 South America
        • 7.1.1.4.1 Brazil
        • 7.1.1.4.2 Rest of South America
      • 7.1.1.5 RoW
        • 7.1.1.5.1 Middle East Region
        • 7.1.1.5.2 Africa Region
    • 7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.3 INDUSTRY STANDARDS
    • 7.1.4 DOCUMENTATION REQUIREMENTS
    • 7.1.5 ANTICIPATED REGULATORY CHANGES IN NEXT 5-10 YEARS
  • 7.2 SUSTAINABILITY INITIATIVES
  • 7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
    • 7.3.1 CERTIFICATIONS, LABELING, ECO-STANDARDS

8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR

  • 8.1 DECISION-MAKING PROCESS
  • 8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
    • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.2.2 BUYING CRITERIA
  • 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
  • 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
  • 8.5 MARKET PROFITABILITY
    • 8.5.1 REVENUE POTENTIAL
    • 8.5.2 COST DYNAMICS
    • 8.5.3 MARGIN OPPORTUNITIES, BY PRODUCT FORMAT

9 PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM

  • 9.1 INTRODUCTION
  • 9.2 TABLETS & SOFTGELS
    • 9.2.1 CONVENIENT DOSAGE FORMAT SUPPORTING DEMAND FOR PROBIOTIC TABLET SUPPLEMENTS
  • 9.3 CAPSULES
    • 9.3.1 HIGH STABILITY AND STRAIN PROTECTION DRIVING DEMAND FOR PROBIOTIC CAPSULES
  • 9.4 POWDER
    • 9.4.1 FLEXIBLE DOSING AND PEDIATRIC APPLICATIONS DRIVING DEMAND FOR PROBIOTIC POWDER FORMULATIONS
  • 9.5 GUMMIES & CHEWABLES
    • 9.5.1 INCREASING FOCUS ON PALATABLE AND CONSUMER-FRIENDLY SUPPLEMENTS DRIVING GUMMY PROBIOTIC DEMAND
  • 9.6 LIQUID
    • 9.6.1 RAPID ABSORPTION AND PEDIATRIC SUITABILITY SUPPORTING DEMAND FOR LIQUID PROBIOTIC FORMULATIONS
  • 9.7 OTHER PRODUCT FORMS

10 PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL

  • 10.1 INTRODUCTION
  • 10.2 HYPERMARKETS/SUPERMARKETS
    • 10.2.1 HIGH PRODUCT VISIBILITY AND CONSUMER ACCESSIBILITY SUPPORTING PROBIOTIC SALES THROUGH MODERN RETAIL CHANNELS
  • 10.3 PHARMACIES/DRUGSTORES
    • 10.3.1 STRONG CONSUMER TRUST AND HEALTHCARE-ORIENTED PURCHASING DRIVING PROBIOTIC SALES THROUGH PHARMACIES
  • 10.4 SPECIALTY STORES
    • 10.4.1 RISING POPULARITY OF PREMIUM AND TARGETED NUTRITION PRODUCTS DRIVING GROWTH OF SPECIALTY HEALTH STORES
  • 10.5 E-COMMERCE
    • 10.5.1 RAPID DIGITALIZATION AND ONLINE WELLNESS PURCHASING FUELING EXPANSION OF E-COMMERCE CHANNELS
  • 10.6 OTHER DISTRIBUTION CHANNELS

11 PROBIOTIC SUPPLEMENTS MARKET, BY END USER

  • 11.1 INTRODUCTION
  • 11.2 INFANTS
    • 11.2.1 INCREASING FOCUS ON EARLY-LIFE MICROBIOME DEVELOPMENT DRIVING DEMAND FOR INFANT PROBIOTIC SUPPLEMENTS
  • 11.3 CHILDREN
    • 11.3.1 RISING PARENTAL AWARENESS REGARDING PEDIATRIC IMMUNITY AND DIGESTIVE WELLNESS DRIVING DEMAND FOR PROBIOTIC SUPPLEMENTS
  • 11.4 ADULTS
    • 11.4.1 INCREASING PREVALENCE OF LIFESTYLE-RELATED HEALTH CONDITIONS SUPPORTING ADULT PROBIOTIC CONSUMPTION
  • 11.5 GERIATRIC POPULATION
    • 11.5.1 GROWING AGING POPULATION AND DIGESTIVE HEALTH CONCERNS DRIVING DEMAND FOR PROBIOTIC SUPPLEMENTS AMONG GERIATRIC CONSUMERS

12 PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION

  • 12.1 INTRODUCTION
  • 12.2 DIGESTIVE HEALTH
    • 12.2.1 GROWING PREVALENCE OF GASTROINTESTINAL DISORDERS SUPPORTING DEMAND FOR DIGESTIVE HEALTH PROBIOTIC SUPPLEMENTS
  • 12.3 IMMUNITY SUPPORT
    • 12.3.1 INCREASING FOCUS ON IMMUNE RESILIENCE DRIVING ADOPTION OF IMMUNITY SUPPORT PROBIOTIC SUPPLEMENTS
  • 12.4 WOMEN'S HEALTH
    • 12.4.1 RISING FOCUS ON VAGINAL, URINARY, AND HORMONAL WELLNESS DRIVING DEMAND FOR WOMEN'S HEALTH PROBIOTIC SUPPLEMENTS
  • 12.5 METABOLIC HEALTH
    • 12.5.1 RISING PREVALENCE OF OBESITY AND LIFESTYLE DISORDERS SUPPORTING DEMAND FOR METABOLIC HEALTH PROBIOTIC SUPPLEMENTS
  • 12.6 ORAL HEALTH
    • 12.6.1 RISING PREVALENCE OF DENTAL CARIES, GINGIVITIS, AND ORAL MICROBIOME IMBALANCE DRIVING DEMAND FOR ORAL HEALTH PROBIOTIC SUPPLEMENTS
  • 12.7 OTHER HEALTH APPLICATIONS

13 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT

  • 13.1 INTRODUCTION
  • 13.2 BACTERIA
    • 13.2.1 STRONG CLINICAL VALIDATION AND WIDESPREAD DIGESTIVE HEALTH APPLICATIONS SUPPORTING BACTERIAL PROBIOTIC DOMINANCE
    • 13.2.2 LACTOBACILLI
    • 13.2.3 BIFIDOBACTERIUM
    • 13.2.4 BACILLUS
    • 13.2.5 STREPTOCOCCUS THERMOPHILUS
  • 13.3 YEAST
    • 13.3.1 INCREASING UTILIZATION OF STABLE MICROORGANISM STRAINS SUPPORTING YEAST-BASED PROBIOTICS DEMAND
    • 13.3.2 SACCHAROMYCES BOULARDII
    • 13.3.3 OTHER YEASTS

14 PROBIOTIC SUPPLEMENTS MARKET, BY REGION

  • 14.1 INTRODUCTION
  • 14.2 NORTH AMERICA
    • 14.2.1 US
      • 14.2.1.1 Strong microbiome health awareness and high functional supplement adoption to drive market
    • 14.2.2 CANADA
      • 14.2.2.1 Growing functional food consumption and strong regulatory oversight to support market growth
    • 14.2.3 MEXICO
      • 14.2.3.1 Rising health awareness and expanding functional nutrition demand to support market development
  • 14.3 EUROPE
    • 14.3.1 GERMANY
      • 14.3.1.1 Strong dietary supplement industry and increasing preventive healthcare awareness to support market growth
    • 14.3.2 UK
      • 14.3.2.1 Expanding e-commerce healthcare retail and growing gut health awareness to drive market
    • 14.3.3 FRANCE
      • 14.3.3.1 Strong preventive healthcare culture and scientific engagement to support market expansion
    • 14.3.4 SPAIN
      • 14.3.4.1 Growing consumer awareness and increasing digestive health focus to support market growth
    • 14.3.5 ITALY
      • 14.3.5.1 High consumer familiarity with probiotics and strong pharmacy distribution channels to support market expansion
    • 14.3.6 REST OF EUROPE
  • 14.4 ASIA PACIFIC
    • 14.4.1 CHINA
      • 14.4.1.1 Growing digestive health awareness and expanding nutraceutical industry to drive market
    • 14.4.2 JAPAN
      • 14.4.2.1 High consumer awareness regarding gut health and strong healthy aging demand to support market expansion
    • 14.4.3 SOUTH KOREA
      • 14.4.3.1 Strong functional nutrition culture and expanding online supplement sales to support market growth
    • 14.4.4 INDIA
      • 14.4.4.1 Rising digestive health concerns and expanding nutraceutical industry to drive market
    • 14.4.5 AUSTRALIA & NEW ZEALAND
      • 14.4.5.1 Strong preventive healthcare culture and high supplement consumption to support market expansion
    • 14.4.6 REST OF ASIA PACIFIC
  • 14.5 SOUTH AMERICA
    • 14.5.1 BRAZIL
      • 14.5.1.1 Large consumer base, expanding dietary supplement industry, and rising gut health awareness to support market growth
    • 14.5.2 ARGENTINA
      • 14.5.2.1 Increasing healthcare awareness and growing preventive nutrition adoption to support market expansion
    • 14.5.3 REST OF SOUTH AMERICA
  • 14.6 REST OF THE WORLD
    • 14.6.1 MIDDLE EAST
      • 14.6.1.1 High healthcare expenditure, rising lifestyle-related diseases, and growing wellness consumption to drive market
    • 14.6.2 AFRICA
      • 14.6.2.1 Rising healthcare awareness, growing digestive health concerns, and expanding pharmacy retail infrastructure to drive market

15 COMPETITIVE LANDSCAPE

  • 15.1 OVERVIEW
  • 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020-2026
  • 15.3 REVENUE ANALYSIS, 2023-2025
  • 15.4 MARKET SHARE ANALYSIS, 2025
  • 15.5 BRAND COMPARISON
  • 15.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 15.6.1 STARS
    • 15.6.2 EMERGING LEADERS
    • 15.6.3 PERVASIVE PLAYERS
    • 15.6.4 PARTICIPANTS
    • 15.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 15.6.5.1 Company footprint
      • 15.6.5.2 Region footprint
      • 15.6.5.3 Health application footprint
      • 15.6.5.4 Product form footprint
      • 15.6.5.5 End user footprint
  • 15.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
    • 15.7.1 PROGRESSIVE COMPANIES
    • 15.7.2 RESPONSIVE COMPANIES
    • 15.7.3 DYNAMIC COMPANIES
    • 15.7.4 STARTING BLOCKS
    • 15.7.5 COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2025
      • 15.7.5.1 Detailed list of key startups/SMEs
      • 15.7.5.2 Competitive benchmarking of key startups/SMEs
  • 15.8 COMPANY VALUATION AND FINANCIAL METRICS
    • 15.8.1 COMPANY VALUATION
    • 15.8.2 EV/EBITDA
  • 15.9 COMPETITIVE SCENARIO
    • 15.9.1 PRODUCT LAUNCHES
    • 15.9.2 DEALS
    • 15.9.3 EXPANSIONS

16 COMPANY PROFILES

  • 16.1 KEY PLAYERS
    • 16.1.1 NESTLE S.A.
      • 16.1.1.1 Business overview
      • 16.1.1.2 Products/Solutions/Services offered
      • 16.1.1.3 Recent developments
        • 16.1.1.3.1 Deals
      • 16.1.1.4 MnM view
        • 16.1.1.4.1 Right to win
        • 16.1.1.4.2 Strategic choices
        • 16.1.1.4.3 Weaknesses and competitive threats
    • 16.1.2 YAKULT HONSHA CO., LTD.
      • 16.1.2.1 Business overview
      • 16.1.2.2 Products/Solutions/Services offered
      • 16.1.2.3 Recent developments
        • 16.1.2.3.1 Product launches
        • 16.1.2.3.2 Deals
      • 16.1.2.4 MnM view
        • 16.1.2.4.1 Right to win
        • 16.1.2.4.2 Strategic choices
        • 16.1.2.4.3 Weaknesses and competitive threats
    • 16.1.3 BIOGAIA
      • 16.1.3.1 Business overview
      • 16.1.3.2 Products/Solutions/Services offered
      • 16.1.3.3 Recent developments
        • 16.1.3.3.1 Product launches
        • 16.1.3.3.2 Deals
      • 16.1.3.4 MnM view
        • 16.1.3.4.1 Right to win
        • 16.1.3.4.2 Strategic choices
        • 16.1.3.4.3 Weaknesses and competitive threats
    • 16.1.4 KERRY GROUP PLC
      • 16.1.4.1 Business overview
      • 16.1.4.2 Products/Solutions/Services offered
      • 16.1.4.3 Recent developments
        • 16.1.4.3.1 Deals
      • 16.1.4.4 MnM view
        • 16.1.4.4.1 Right to win
        • 16.1.4.4.2 Strategic choices
        • 16.1.4.4.3 Weaknesses and competitive threats
    • 16.1.5 AMWAY
      • 16.1.5.1 Business overview
      • 16.1.5.2 Products/Solutions/Services offered
      • 16.1.5.3 Recent developments
        • 16.1.5.3.1 Product launches
      • 16.1.5.4 MnM view
        • 16.1.5.4.1 Right to win
        • 16.1.5.4.2 Strategic choices
        • 16.1.5.4.3 Weaknesses and competitive threats
    • 16.1.6 NATURE'S WAY
      • 16.1.6.1 Business overview
      • 16.1.6.2 Products/Solutions/Services offered
      • 16.1.6.3 Recent developments
        • 16.1.6.3.1 Expansions
      • 16.1.6.4 MnM view
    • 16.1.7 HERBALIFE LTD.
      • 16.1.7.1 Business overview
      • 16.1.7.2 Products/Solutions/Services offered
      • 16.1.7.3 Recent developments
        • 16.1.7.3.1 Deals
      • 16.1.7.4 MnM view
    • 16.1.8 MORINAGA MILK INDUSTRY CO., LTD.
      • 16.1.8.1 Business overview
      • 16.1.8.2 Products/Solutions/Services offered
      • 16.1.8.3 Recent developments
        • 16.1.8.3.1 Deals
      • 16.1.8.4 MnM view
    • 16.1.9 JARROW FORMULAS, INC.
      • 16.1.9.1 Business overview
      • 16.1.9.2 Products/Solutions/Services offered
      • 16.1.9.3 Recent developments
        • 16.1.9.3.1 Product launches
        • 16.1.9.3.2 Deals
      • 16.1.9.4 MnM view
    • 16.1.10 SYMRISE AG
      • 16.1.10.1 Business overview
      • 16.1.10.2 Products/Solutions/Services offered
      • 16.1.10.3 Recent developments
        • 16.1.10.3.1 Product launches
      • 16.1.10.4 MnM view
    • 16.1.11 METAGENICS, INC.
      • 16.1.11.1 Business overview
      • 16.1.11.2 Products/Solutions/Services offered
      • 16.1.11.3 Recent developments
        • 16.1.11.3.1 Deals
      • 16.1.11.4 MnM view
    • 16.1.12 OPTIBIOTIX HEALTH PLC
      • 16.1.12.1 Business overview
      • 16.1.12.2 Products/Solutions/Services offered
      • 16.1.12.3 Recent developments
      • 16.1.12.4 MnM view
    • 16.1.13 OPTIBAC PROBIOTICS LTD.
      • 16.1.13.1 Business overview
      • 16.1.13.2 Products/Solutions/Services offered
      • 16.1.13.3 Recent developments
        • 16.1.13.3.1 Product launches
      • 16.1.13.4 MnM view
    • 16.1.14 AB-BIOTICS S.A.
      • 16.1.14.1 Business overview
      • 16.1.14.2 Products/Solutions/Services offered
      • 16.1.14.3 Recent developments
        • 16.1.14.3.1 Deals
      • 16.1.14.4 MnM view
    • 16.1.15 LIFEWAY FOODS, INC.
      • 16.1.15.1 Business overview
      • 16.1.15.2 Products/Solutions/Services offered
      • 16.1.15.3 Recent developments
      • 16.1.15.4 MnM view
  • 16.2 STARTUPS/SMES
    • 16.2.1 SEED HEALTH, INC.
      • 16.2.1.1 Business overview
      • 16.2.1.2 Products/Solutions/Services offered
      • 16.2.1.3 Recent developments
        • 16.2.1.3.1 Product launches
      • 16.2.1.4 MnM view
    • 16.2.2 PENDULUM THERAPEUTICS
      • 16.2.2.1 Business overview
      • 16.2.2.2 Products/Solutions/Services offered
      • 16.2.2.3 Recent developments
        • 16.2.2.3.1 Product launches
        • 16.2.2.3.2 Deals
      • 16.2.2.4 MnM view
    • 16.2.3 FLORE INC.
      • 16.2.3.1 Business overview
      • 16.2.3.2 Products/Solutions/Services offered
      • 16.2.3.3 Recent developments
      • 16.2.3.4 MnM view
    • 16.2.4 CUSTOM PROBIOTICS INC.
      • 16.2.4.1 Business overview
      • 16.2.4.2 Products/Solutions/Services offered
      • 16.2.4.3 Recent developments
      • 16.2.4.4 MnM view
    • 16.2.5 ORA ORGANIC
      • 16.2.5.1 Business overview
      • 16.2.5.2 Products/Solutions/Services offered
      • 16.2.5.3 Recent developments
      • 16.2.5.4 MnM view
    • 16.2.6 LOVEBUG PROBIOTICS
    • 16.2.7 BIOHM HEALTH
    • 16.2.8 TONIIQ
    • 16.2.9 FITBIOMICS
    • 16.2.10 RESBIOTIC NUTRITION

17 RESEARCH METHODOLOGY

  • 17.1 RESEARCH DATA
    • 17.1.1 SECONDARY DATA
      • 17.1.1.1 Key data from secondary sources
    • 17.1.2 PRIMARY DATA
      • 17.1.2.1 Key data from primary sources
      • 17.1.2.2 Breakdown of primary profiles
      • 17.1.2.3 Key insights from industry experts
  • 17.2 MARKET SIZE ESTIMATION
    • 17.2.1 SUPPLY SIDE
  • 17.3 DATA TRIANGULATION
  • 17.4 RESEARCH ASSUMPTIONS
  • 17.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT

18 ADJACENT & RELATED MARKETS

  • 18.1 INTRODUCTION
  • 18.2 LIMITATIONS
  • 18.3 NUTRACEUTICAL INGREDIENTS MARKET
    • 18.3.1 MARKET DEFINITION
    • 18.3.2 MARKET OVERVIEW
  • 18.4 PROBIOTICS MARKET
    • 18.4.1 MARKET DEFINITION
    • 18.4.2 MARKET OVERVIEW

19 APPENDIX

  • 19.1 DISCUSSION GUIDE
  • 19.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 19.3 CUSTOMIZATION OPTIONS
  • 19.4 RELATED REPORTS
  • 19.5 AUTHOR DETAILS
Product Code: FB 10527

List of Tables

  • TABLE 1 USD EXCHANGE RATES, 2020-2024
  • TABLE 2 IMPACT OF PORTER'S FIVE FORCES ON PROBIOTIC SUPPLEMENTS MARKET
  • TABLE 3 ROLES OF COMPANIES IN PROBIOTIC SUPPLEMENTS MARKET ECOSYSTEM
  • TABLE 4 IMPORT DATA RELATED TO HS CODE 300490-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2025-2023 (KG)
  • TABLE 5 EXPORT DATA RELATED TO HS CODE 300490-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2025-2023 (KG)
  • TABLE 6 PROBIOTIC SUPPLEMENTS MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026-2027
  • TABLE 7 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 8 TOP USE CASES AND MARKET POTENTIAL
  • TABLE 9 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES
  • TABLE 10 PROBIOTIC SUPPLEMENTS MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION
  • TABLE 11 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
  • TABLE 12 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 GLOBAL INDUSTRY STANDARDS IN PROBIOTIC SUPPLEMENTS MARKET
  • TABLE 18 DOCUMENTATION REQUIREMENTS AND CLAIMS IN PROBIOTIC SUPPLEMENTS MARKET
  • TABLE 19 CERTIFICATIONS, ACCREDITATION, AND ECO-STANDARDS IN PROBIOTIC SUPPLEMENTS MARKET
  • TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT FORMAT
  • TABLE 21 KEY BUYING CRITERIA, BY PRODUCT FORMAT
  • TABLE 22 UNMET NEEDS IN PROBIOTIC SUPPLEMENTS MARKET, BY END-USE APPLICATION
  • TABLE 23 COST DYNAMICS IN PROBIOTIC SUPPLEMENTS MARKET
  • TABLE 24 MARGIN OPPORTUNITIES IN PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORMAT
  • TABLE 25 PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 26 PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 27 PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (TONS)
  • TABLE 28 PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (TONS)
  • TABLE 29 TABLETS & SOFTGELS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 30 TABLETS & SOFTGELS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 31 CAPSULES: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 32 CAPSULES: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 33 POWDER: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 34 POWDER: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 35 GUMMIES & CHEWABLES: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 36 GUMMIES & CHEWABLES: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 37 LIQUID: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 38 LIQUID: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 39 OTHER PRODUCT FORMS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 40 OTHER PRODUCT FORMS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 41 PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 42 PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 43 HYPERMARKETS/SUPERMARKETS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 44 HYPERMARKETS/SUPERMARKETS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 45 PHARMACIES/DRUGSTORES: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 46 PHARMACIES/DRUGSTORES: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 47 SPECIALTY STORES: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 48 SPECIALTY STORES: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 49 E-COMMERCE: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 50 E-COMMERCE: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 51 OTHER DISTRIBUTION CHANNELS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 52 OTHER DISTRIBUTION CHANNELS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 53 PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2022-2025 (USD MILLION)
  • TABLE 54 PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2026-2031 (USD MILLION)
  • TABLE 55 INFANTS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 56 INFANTS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 57 CHILDREN: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 58 CHILDREN: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 59 ADULTS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 60 ADULTS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 61 GERIATRIC POPULATION: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 62 GERIATRIC POPULATION: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 63 PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 64 PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 65 DIGESTIVE HEALTH: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 66 DIGESTIVE HEALTH: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 67 IMMUNITY SUPPORT: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 68 IMMUNITY SUPPORT: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 69 WOMEN'S HEALTH: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 70 WOMEN'S HEALTH: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 71 METABOLIC HEALTH: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 72 METABOLIC HEALTH: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 73 ORAL HEALTH: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 74 ORAL HEALTH: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 75 OTHER HEALTH APPLICATIONS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 76 OTHER HEALTH APPLICATIONS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 77 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2022-2025 (USD MILLION)
  • TABLE 78 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2026-2031 (USD MILLION)
  • TABLE 79 BACTERIA: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 80 BACTERIA: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 81 YEAST: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 82 YEAST: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 83 PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 84 PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 85 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY, 2022-2025 (USD MILLION)
  • TABLE 86 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
  • TABLE 87 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 88 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 89 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 90 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 91 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (TONS)
  • TABLE 92 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (TONS)
  • TABLE 93 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 94 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 95 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2022-2025 (USD MILLION)
  • TABLE 96 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2026-2031 (USD MILLION)
  • TABLE 97 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2022-2025 (USD MILLION)
  • TABLE 98 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2026-2031 (USD MILLION)
  • TABLE 99 US: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 100 US: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 101 US: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 102 US: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 103 CANADA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 104 CANADA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 105 CANADA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 106 CANADA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 107 MEXICO: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 108 MEXICO: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 109 MEXICO: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 110 MEXICO: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 111 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY, 2022-2025 (USD MILLION)
  • TABLE 112 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
  • TABLE 113 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 114 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 115 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 116 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 117 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (TONS)
  • TABLE 118 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (TONS)
  • TABLE 119 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 120 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 121 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2022-2025 (USD MILLION)
  • TABLE 122 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2026-2031 (USD MILLION)
  • TABLE 123 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2022-2025 (USD MILLION)
  • TABLE 124 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2026-2031 (USD MILLION)
  • TABLE 125 GERMANY: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 126 GERMANY: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 127 GERMANY: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 128 GERMANY: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 129 UK: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 130 UK: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 131 UK: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 132 UK: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 133 FRANCE: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 134 FRANCE: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 135 FRANCE: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 136 FRANCE: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 137 SPAIN: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 138 SPAIN: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 139 SPAIN: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 140 SPAIN: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 141 ITALY: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 142 ITALY: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 143 ITALY: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 144 ITALY: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 145 REST OF EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 146 REST OF EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 147 REST OF EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 148 REST OF EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY, 2022-2025 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 154 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 155 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (TONS)
  • TABLE 156 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (TONS)
  • TABLE 157 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 158 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2022-2025 (USD MILLION)
  • TABLE 160 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2026-2031 (USD MILLION)
  • TABLE 161 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2022-2025 (USD MILLION)
  • TABLE 162 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2026-2031 (USD MILLION)
  • TABLE 163 CHINA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 164 CHINA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 165 CHINA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 166 CHINA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 167 JAPAN: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 168 JAPAN: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 169 JAPAN: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 170 JAPAN: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 171 SOUTH KOREA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 172 SOUTH KOREA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 173 SOUTH KOREA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 174 SOUTH KOREA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 175 INDIA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 176 INDIA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 177 INDIA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 178 INDIA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 179 AUSTRALIA & NEW ZEALAND: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 180 AUSTRALIA & NEW ZEALAND: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 181 AUSTRALIA & NEW ZEALAND: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 182 AUSTRALIA & NEW ZEALAND: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 183 REST OF ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 184 REST OF ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 185 REST OF ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 186 REST OF ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 187 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY, 2022-2025 (USD MILLION)
  • TABLE 188 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
  • TABLE 189 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 190 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 191 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 192 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 193 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (TONS)
  • TABLE 194 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (TONS)
  • TABLE 195 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 196 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 197 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2022-2025 (USD MILLION)
  • TABLE 198 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2026-2031 (USD MILLION)
  • TABLE 199 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2022-2025 (USD MILLION)
  • TABLE 200 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2026-2031 (USD MILLION)
  • TABLE 201 BRAZIL: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 202 BRAZIL: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 203 BRAZIL: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 204 BRAZIL: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 205 ARGENTINA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 206 ARGENTINA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 207 ARGENTINA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 208 ARGENTINA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 209 REST OF SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 210 REST OF SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 211 REST OF SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 212 REST OF SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 213 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 214 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 215 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 216 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 217 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 218 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 219 ROW: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (TONS)
  • TABLE 220 ROW: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (TONS)
  • TABLE 221 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 222 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 223 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2022-2025 (USD MILLION)
  • TABLE 224 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2026-2031 (USD MILLION)
  • TABLE 225 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2022-2025 (USD MILLION)
  • TABLE 226 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2026-2031 (USD MILLION)
  • TABLE 227 MIDDLE EAST: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 228 MIDDLE EAST: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 229 MIDDLE EAST: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 230 MIDDLE EAST: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 231 AFRICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 232 AFRICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 233 AFRICA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 234 AFRICA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 235 OVERVIEW OF STRATEGIES ADOPTED BY KEY PROBIOTIC SUPPLEMENTS VENDORS, 2020-2026
  • TABLE 236 PROBIOTIC SUPPLEMENTS MARKET: DEGREE OF COMPETITION
  • TABLE 237 PROBIOTIC SUPPLEMENTS MARKET: REGION FOOTPRINT
  • TABLE 238 PROBIOTIC SUPPLEMENTS MARKET: HEALTH APPLICATION FOOTPRINT
  • TABLE 239 PROBIOTIC SUPPLEMENTS S MARKET: PRODUCT FORM FOOTPRINT
  • TABLE 240 PROBIOTIC SUPPLEMENTS S MARKET: END USER FOOTPRINT
  • TABLE 241 PROBIOTIC SUPPLEMENTS MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2025
  • TABLE 242 PROBIOTIC SUPPLEMENTS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 243 PROBIOTIC SUPPLEMENTS MARKET: PRODUCT LAUNCHES, 2020-MAY 2026
  • TABLE 244 PROBIOTIC SUPPLEMENTS MARKET: DEALS, 2020-MAY 2026
  • TABLE 245 PROBIOTIC SUPPLEMENTS MARKET: EXPANSIONS, JANUARY 2022-APRIL 2026
  • TABLE 246 NESTLE S.A.: COMPANY OVERVIEW
  • TABLE 247 NESTLE S.A.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 248 NESTLE S.A.: DEALS
  • TABLE 249 YAKULT HONSHA CO., LTD.: COMPANY OVERVIEW
  • TABLE 250 YAKULT HONSHA CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 251 YAKULT HONSHA CO., LTD.: PRODUCT LAUNCHES
  • TABLE 252 YAKULT HONSHA CO., LTD.: DEALS
  • TABLE 253 BIOGAIA: COMPANY OVERVIEW
  • TABLE 254 BIOGAIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 255 BIOGAIA: PRODUCT LAUNCHES
  • TABLE 256 BIOGAIA: DEALS
  • TABLE 257 KERRY GROUP PLC: COMPANY OVERVIEW
  • TABLE 258 KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 259 KERRY GROUP PLC: DEALS
  • TABLE 260 AMWAY: COMPANY OVERVIEW
  • TABLE 261 AMWAY: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 262 AMWAY: PRODUCT LAUNCHES
  • TABLE 263 NATURE'S WAY: COMPANY OVERVIEW
  • TABLE 264 NATURE'S WAY: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 265 NATURE'S WAY: EXPANSIONS
  • TABLE 266 HERBALIFE LTD.: COMPANY OVERVIEW
  • TABLE 267 HERBALIFE LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 268 HERBALIFE LTD.: DEALS
  • TABLE 269 MORINAGA MILK INDUSTRY CO., LTD.: COMPANY OVERVIEW
  • TABLE 270 MORINAGA MILK INDUSTRY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 271 MORINAGA MILK INDUSTRY CO., LTD.: DEALS
  • TABLE 272 JARROW FORMULAS, INC.: COMPANY OVERVIEW
  • TABLE 273 JARROW FORMULAS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 274 JARROW FORMULAS, INC.: PRODUCT LAUNCHES
  • TABLE 275 JARROW FORMULAS, INC.: DEALS
  • TABLE 276 SYMRISE AG: COMPANY OVERVIEW
  • TABLE 277 SYMRISE AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 278 SYMRISE AG: PRODUCT LAUNCHES
  • TABLE 279 METAGENICS, INC.: BUSINESS OVERVIEW
  • TABLE 280 METAGENICS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 281 METAGENICS, INC.: DEALS
  • TABLE 282 OPTIBIOTIX HEALTH PLC: COMPANY OVERVIEW
  • TABLE 283 OPTIBIOTIX HEALTH PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 284 OPTIBAC PROBIOTICS LTD.: COMPANY OVERVIEW
  • TABLE 285 OPTIBAC PROBIOTICS LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 286 OPTIBAC PROBIOTICS LTD.: PRODUCT LAUNCHES
  • TABLE 287 AB-BIOTICS S.A.: COMPANY OVERVIEW
  • TABLE 288 AB-BIOTICS S.A.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 289 AB-BIOTICS S.A.: DEALS
  • TABLE 290 LIFEWAY FOODS, INC.: COMPANY OVERVIEW
  • TABLE 291 LIFEWAY FOODS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 292 SEED HEALTH, INC.: COMPANY OVERVIEW
  • TABLE 293 SEED HEALTH, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 294 SEED HEALTH, INC.: PRODUCT LAUNCHES
  • TABLE 295 PENDULUM THERAPEUTICS: COMPANY OVERVIEW
  • TABLE 296 PENDULUM THERAPEUTICS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 297 PENDULUM THERAPEUTICS: PRODUCT LAUNCHES
  • TABLE 298 PENDULUM THERAPEUTICS: DEALS
  • TABLE 299 FLORE INC.: COMPANY OVERVIEW
  • TABLE 300 FLORE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 301 CUSTOM PROBIOTICS INC.: COMPANY OVERVIEW
  • TABLE 302 CUSTOM PROBIOTICS INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 303 ORA ORGANIC: COMPANY OVERVIEW
  • TABLE 304 ORA ORGANIC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 305 LOVEBUG PROBIOTICS: BUSINESS OVERVIEW
  • TABLE 306 BIOHM HEALTH: BUSINESS OVERVIEW
  • TABLE 307 TONIIQ: BUSINESS OVERVIEW
  • TABLE 308 FITBIOMICS: BUSINESS OVERVIEW
  • TABLE 309 RESBIOTIC NUTRITION: BUSINESS OVERVIEW
  • TABLE 310 ADJACENT MARKETS TO PROBIOTIC SUPPLEMENTS MARKET
  • TABLE 311 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 312 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 313 PROBIOTICS MARKET, BY REGION, 2020-2023 (USD BILLION)
  • TABLE 314 PROBIOTICS MARKET, BY REGION, 2024-2029 (USD BILLION)

List of Figures

  • FIGURE 1 MARKET SCENARIO
  • FIGURE 2 PROBIOTIC SUPPLEMENTS MARKET, 2022-2031
  • FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PROBIOTIC SUPPLEMENTS MARKET, 2020-JANUARY 2026
  • FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF PROBIOTIC SUPPLEMENTS MARKET
  • FIGURE 5 HIGH-GROWTH SEGMENTS IN PROBIOTIC SUPPLEMENTS MARKET, 2026-2031
  • FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 7 RISING CONSUMER FOCUS ON GUT HEALTH, IMMUNITY, AND PREVENTIVE HEALTHCARE TO DRIVE MARKET
  • FIGURE 8 CAPSULES SEGMENT AND ASIA PACIFIC TO ACCOUNT FOR LARGEST MARKET SHARES IN 2026
  • FIGURE 9 BACTERIA SEGMENT TO DOMINATE MARKET IN 2026
  • FIGURE 10 E-COMMERCE SEGMENT TO LEAD MARKET IN 2026
  • FIGURE 11 ADULTS SEGMENT TO DOMINATE MARKET IN 2026
  • FIGURE 12 DIGESTIVE & GUT HEALTH SEGMENT TO DOMINATE MARKET IN 2026
  • FIGURE 13 US TO LEAD MARKET IN 2026
  • FIGURE 14 PROBIOTIC SUPPLEMENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 15 PROBIOTIC SUPPLEMENTS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 16 WORLD POPULATION, BY ECONOMY, 1950-2050
  • FIGURE 17 POPULATION GROWTH TREND, 1950-2050
  • FIGURE 18 PROBIOTIC SUPPLEMENTS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 19 PROBIOTIC SUPPLEMENTS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 20 AVERAGE SELLING PRICE OF PROBIOTIC SUPPLEMENTS OFFERED BY KEY PLAYERS, BY PRODUCT FORM, 2025 (USD/KG)
  • FIGURE 21 AVERAGE SELLING PRICE OF PROBIOTIC SUPPLEMENTS, BY REGION, 2021-2025 (USD/KG)
  • FIGURE 22 TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS
  • FIGURE 23 INVESTMENT AND FUNDING SCENARIO, 2025
  • FIGURE 24 PATENTS APPLIED AND GRANTED, MAY 2016-MAY 2026
  • FIGURE 25 FUTURE APPLICATIONS
  • FIGURE 26 PROBIOTIC SUPPLEMENTS MARKET DECISION-MAKING FACTORS
  • FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT FORMAT
  • FIGURE 28 KEY BUYING CRITERIA, BY PRODUCT FORMAT
  • FIGURE 29 ADOPTION BARRIERS AND INTERNAL CHALLENGES
  • FIGURE 30 PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026 VS. 2031 (USD MILLION)
  • FIGURE 31 PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026 VS. 2031 (USD MILLION)
  • FIGURE 32 PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2026 VS. 2031 (USD MILLION)
  • FIGURE 33 PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2026 VS. 2031 (USD MILLION)
  • FIGURE 34 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2026 VS. 2031 (USD MILLION)
  • FIGURE 35 PROBIOTIC SUPPLEMENTS MARKET GROWTH, BY KEY COUNTRY, 2026-2031
  • FIGURE 36 EUROPE: PROBIOTIC SUPPLEMENTS MARKET SNAPSHOT
  • FIGURE 37 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET SNAPSHOT
  • FIGURE 38 PROBIOTIC SUPPLEMENTS MARKET: REVENUE ANALYSIS, 2023-2025 (USD BILLION)
  • FIGURE 39 SHARE ANALYSIS OF LEADING COMPANIES IN PROBIOTIC SUPPLEMENTS MARKET, 2025
  • FIGURE 40 COMPARATIVE ANALYSIS OF VENDOR BRANDS
  • FIGURE 41 PROBIOTIC SUPPLEMENTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 42 PROBIOTIC SUPPLEMENTS MARKET: COMPANY FOOTPRINT
  • FIGURE 43 PROBIOTIC SUPPLEMENTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 44 COMPANY VALUATION OF KEY PROBIOTIC SUPPLEMENTS VENDORS
  • FIGURE 45 EV/EBITDA OF KEY COMPANIES
  • FIGURE 46 NESTLE S.A.: COMPANY SNAPSHOT
  • FIGURE 47 YAKULT HONSHA CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 48 BIOGAIA: COMPANY SNAPSHOT
  • FIGURE 49 KERRY GROUP PLC: COMPANY SNAPSHOT
  • FIGURE 50 AMWAY: COMPANY SNAPSHOT
  • FIGURE 51 HERBALIFE LTD.: COMPANY SNAPSHOT
  • FIGURE 52 MORINAGA MILK INDUSTRY CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 53 SYMRISE AG: COMPANY SNAPSHOT
  • FIGURE 54 OPTIBIOTIX HEALTH PLC: COMPANY SNAPSHOT
  • FIGURE 55 LIFEWAY FOODS, INC.: COMPANY SNAPSHOT
  • FIGURE 56 PROBIOTIC SUPPLEMENTS MARKET: RESEARCH DESIGN
  • FIGURE 57 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 58 KEY INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 59 BOTTOM-UP APPROACH (BASED ON DISTRIBUTION CHANNEL, BY REGION)
  • FIGURE 60 TOP-DOWN APPROACH - FROM PARENT MARKET
  • FIGURE 61 PROBIOTIC SUPPLEMENTS MARKET: SUPPLY SIDE ANALYSIS
  • FIGURE 62 DATA TRIANGULATION: SUPPLY SIDE
  • FIGURE 63 DATA TRIANGULATION METHODOLOGY
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!